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Foreword
As the largest organ of the body, the skin performs multiple critical functions, such as 
serving as the primary barrier to the external environment. For this reason, the skin is 
often exposed to potentially hazardous agents, including chemicals, which may contrib-
ute to the onset of a spectrum of adverse health effects ranging from localized damage 
(e.g., irritant contact dermatitis and corrosion) to induction of immune-mediated re-
sponses (e.g., allergic contact dermatitis and pulmonary responses), or systemic toxicity 
(e.g., neurotoxicity and hepatoxicity). Understanding the hazards related to skin contact 
with chemicals is a critical component of modern occupational safety and health pro-
grams. 
In 2009, the National Institute for Occupational Safety and Health (NIOSH) published 
Current Intelligence Bulletin (CIB) 61: A Strategy for Assigning New NIOSH Skin Notations 
[NIOSH 2009–147]. This document provides the scientific rationale and framework 
for the assignment of multiple hazard-specific skin notations (SK) that clearly dis-
tinguish between the systemic effects, direct (localized) effects, and immune-mediated 
responses caused by skin contact with chemicals. The key step within assignment of the 
hazard-specific SK is the determination of a substance’s hazard potential, or its poten-
tial for causing adverse health effects as a result of skin exposure. This determination 
entails a health hazard identification process that involves use of the following: 
 • Scientific data on the physicochemical properties of a chemical
 • Data on human exposures and health effects
 • Empirical data from in vivo and in vitro laboratory testing
 • Computational techniques, including predictive algorithms and mathematical 
models that describe a selected process (e.g., skin permeation) by means of ana-
lytical or numerical methods. 
This Skin Notation Profile provides the SK assignment and supportive data for epichlo-
rohydrin (CAS No. 106–89–8). In particular, this document evaluates and summarizes 
the literature describing the substance’s hazard potential and its assessment according 
to the scientific rationale and framework outlined in CIB 61. In meeting this objective, 
this Skin Notation Profile intends to inform the audience—mostly occupational health 
practitioners, researchers, policy- and decision-makers, employers, and workers in po-
tentially hazardous workplaces—so that improved risk-management practices may be 
developed to better protect workers from the risks of skin contact with the chemical of 
interest. 
John Howard, M.D 
Director, National Institute for Occupational 
   Safety and Health 
Centers for Disease Control and Prevention 
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Abbreviations 
ACGIH American Conference of Governmental Industrial Hygienists 
CIB Current Intelligence Bulletin
cm/hr centimeter(s) per hour
cm/s centimeter(s) per second
(COR) subnotation of SK: DIR indicating the potential for a chemical to be 
  corrosive following exposure of the skin
DEREKTM Deductive Estimation of Risk from Existing Knowledge
DIR skin notation indicating the potential for direct effects to the skin 
   following contact with a chemical
EC European Commission 
GHS Globally Harmonized System of Classification and Labeling of Chemicals
GPMT guinea pig maximization test
IARC International Agency for Research on Cancer
Kaq  coefficient in the watery epidermal layer 
Kp skin permeation coefficient 
Kpol  coefficient in the protein fraction of the stratum corneum
Kpsc  permeation coefficient in the lipid fraction of the stratum corneum 
LD50  dose resulting in 50% mortality in the exposed population
LDLo dermal lethal dose
log KOW base-10 logarithm of a substance’s octanol–water partition
m3 cubic meter(s)
mg milligram(s)
mg/cm2/hr milligram(s) per square centimeter per hour
mg/kg milligram(s) per kilogram body weight
mg/m3 milligram(s) per cubic meter
mL milliliter(s)
mL/kg milliliter(s) per kilogram body weight
MW molecular weight
NIOSH National Institute for Occupational Safety and Health
NTP National Toxicology Program
OEL occupational exposure limit
OSHA Occupational Safety and Health Administration
REL recommended exposure limit
RF retention factor 
SEN skin notation indicating the potential for immune-mediated reactions 
  following exposure of the skin
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SI ratio ratio of skin dose to inhalation dose
SK skin notation
SW  solubility 
SYS skin notation indicating the potential for systemic toxicity following 
   exposure of the skin
USEPA United States Environmental Protection Agency 
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Glossary 
Absorption—The transport of a chemical from the outer surface of the skin into both 
the skin and systemic circulation (including penetration, permeation, and resorption). 
Acute exposure—Contact with a chemical that occurs once or for only a short period 
of time. 
Cancer—Any one of a group of diseases that occurs when cells in the body become 
abnormal and grow or multiply out of control. 
Contaminant—A chemical that is (1) unintentionally present within a neat substance 
or mixture at a concentration less than 1.0% or (2) recognized as a potential carcinogen 
and present within a neat substance or mixture at a concentration less than 0.1%. 
Cutaneous (or percutaneous)—Referring to the skin (or through the skin). 
Dermal—Referring to the skin. 
Dermal contact—Contact with (touching) the skin. 
Direct effects—Localized, non-immune-mediated adverse health effects on the skin, 
including corrosion, primary irritation, changes in skin pigmentation, and reduction/
disruption of the skin barrier integrity, occurring at or near the point of contact with 
chemicals. 
Immune-mediated responses—Responses mediated by the immune system, including 
allergic responses. 
Sensitization—A specific immune-mediated response that develops following expo-
sure to a chemical, which, upon re-exposure, can lead to allergic contact dermatitis 
(ACD) or other immune-mediated diseases such as asthma, depending on the site and 
route of re-exposure. 
Substance—A chemical. 
Systemic effects—Systemic toxicity associated with skin absorption of chemicals after 
exposure of the skin. 
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Epichlorohydrin
1 Introduction 
1.1 General Substance Information
Synonyms:
1-chloro-2,3-epoxypropane; 2-chloropro-
pylene oxide; γ-chloropropylene oxide 
Uses:
Epichlorohydrin is an organochlorine com-
pound and an epoxide used primarily as a 
chemical intermediate in the production of 
epoxy resins and glycerol; it is also applied 
as a raw material for the manufacturing 
of glycerol and glycidol derivatives used as 
plasticizers, stabilizers, solvents, dyestuff in-








This Skin Notation Profile presents (1) brief 
summary of technical data associated with 
skin contact with epichlorohydrin and (2) 
the rationale behind the hazard-specific 
skin notation (SK) assignment for epi-
chlorohydrin. The SK assignment is based 
on the scientific rationale and logic out-
lined in the Current Intelligence Bulletin 
(CIB) 61: A Strategy for Assigning New 
NIOSH Skin Notations [NIOSH 2009]. 
The summarized information and health 
hazard assessment are limited to an evalu-
ation of the potential health effects of 
dermal exposure to epichlorohydrin. A lit-
erature search was conducted through July 
2010 to identify information on epichlo-
rohydrin, including but not limited to data 
relating to its toxicokinetics, acute toxicity, 
repeated-dose systemic toxicity, carcinoge-
nicity, biological system/function–specific 
effects (including reproductive and devel-
opmental effects and immunotoxicity), 
irritation, and sensitization. Information 
was considered from studies of humans, 
animals, or appropriate modeling systems 
that are relevant to assessing the effects of 
dermal exposure to epichlorohydrin. 
1.3 Overview of SK Assignment 
for Epichlorohydrin
Epichlorohydrin is potentially capable of 
causing numerous adverse health effects 
following skin contact. A critical review of 
available data has resulted in the following 
SK assignment for epichlorohydrin: SK: 
Cl
O
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SYS-DIR (COR)-SEN. Table 1 provides 
an overview of the critical effects and data 
used to develop the SK assignment for 
epichlorohydrin. 
2 Systemic Toxicity from Skin 
Exposure (SK: SYS) 
There are few data on the absorption 
potential of epichlorohydrin in humans 
and animals following dermal exposure. 
A few studies of animals were identified 
that showed epichlorohydrin is absorbed 
when the chemical is in contact with the 
skin. For example, immersion of the tails 
of mice in undiluted epichlorohydrin for 
15 to 60 minutes resulted in the death of 
most mice, indicating systemic poisoning 
that likely resulted from dermal absorp-
tion [Kremneva and Tolgskaja 1961; Pal-
lade et al. 1967]. Lawrence et al. [1972] 
reported that rabbits died within 7 days 
following occluded application of epichlo-
rohydrin to the shaved skin for 24 hours. 
Although these studies did not measure 
the extent of absorption, it can be con-
cluded on the basis of the observed effects 
that the chemical was absorbed through 
the skin following dermal contact. The po-
tential of epichlorohydrin to pose a skin 
absorption hazard was also evaluated with 
use of a predictive algorithm for estimat-
ing and evaluating the health hazards of 
dermal exposure to chemical substances 
[NIOSH 2009]. The evaluation method 
compares an estimated chemical dose ac-
cumulated in the body from skin absorp-
tion and an estimated dose from respira-
tory absorption associated with a reference 
occupational exposure limit. On the basis 
of this algorithm, a ratio of skin dose to 
inhalation dose (SI ratio) of 22.7 was cal-
culated for epichlorohydrin. An SI ratio of 
≥0.1 indicates that a chemical is capable 
of producing systemic toxicity from skin 
exposure [NIOSH 2009]. Additional in-
formation on the SI ratio and the variables 
used in its calculation are included in the 
appendix. 
The dermal lethal dose (LDLo) for humans 
has not been determined. However, values 
for dermal LD50 in rabbits (the dose result-
ing in 50% mortality in the exposed popu-
lation) have been reported to range from 
515 to 1038 milligrams per kilogram body 
weight (mg/kg) [Mellon Institute 1970; 
Shell Chemical Company 1977; Hine et 
al. 1981] or from 0.6389 to 1.3 milliliters 
per kilogram body weight (mL/kg) (cor-
responding to 750 to 1528 mg/kg) [Weil 
et al. 1963; Lawrence et al. 1972]. A der-
mal LD50 of greater than 1.0 mL/kg (cor-
responding to 1175 mg/kg) was reported 
for male rats after a 7-day exposure; no 
toxicity symptoms were detectable in the 
animals under the conditions of the study 
[Mobay Chemical Corporation 1967]. Dow 
Table 1. Summary of the SK assignment for epichlorohydrin
Skin notation Critical effect(s) Available data
SK: SYS Acute toxicity; Respiratory depression Limited animal data
SK: DIR(COR) Skin corrosion; skin tumors (cancer) Limited human data; limited 
animal data
SK: SEN Skin allergy Sufficient human data; limited 
animal data
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Chemical Company [1976] reported a 
dermal LD50 value of 515 mg/kg for undi-
luted epichlorohydrin and 250 to 500 mg/
kg for a 20% solution in propylene glycol. 
Because the reported acute dermal LD50 
values for the rabbit and mouse are both 
lower than the critical dermal LD50 value 
of 2000 mg/kg that identifies chemical 
substances with the potential for acute 
dermal toxicity [NIOSH 2009], epichlo-
rohydrin is considered systemically toxic 
by the acute dermal route. 
No data from epidemiological studies of 
humans were identified. The literature search 
revealed only one study involving experi-
mental animals and repeat-dose dermal 
exposures to epichlorohydrin; in that study, 
gradual depression of respiration leading 
to death occurred after repeated applica-
tion of 0.5 mL/kg to the skin of rats [Shell 
Chemical Company 1977]. 
In addition, no standard toxicity or spe-
cialty studies evaluating biological system/
function–specific effects (including repro-
ductive and developmental effects and im-
munotoxicity) following dermal exposure 
were identified. However, limited data were 
noted on the potential for epichlorohydrin 
to cause cancer in experimental animals. 
The chemical yielded negative results af-
ter continuous skin painting in mice, in 
the absence of a tumor promoter [Weil et 
al. 1963; Van Duuren et al. 1974]. Table 2 
provides a summary of carcinogenic desig-
nations for epichlorohydrin from multiple 
governmental and nongovernmental orga-
nizations. 
Taken together, the data on systemic ef-
fects in animals [Lawrence et al. 1972*], 
acute toxicity in rabbits [Lawrence et al. 
1972; Hine et al. 1981], and repeat-dose 
toxicity [Shell Chemical Company 1977] 
are sufficient to demonstrate that epichlo-
rohydrin is systemically available and toxic 
following dermal exposure. Therefore, on 
the basis of the data for this assessment, 
epichlorohydrin is assigned the SK: SYS 
notation. 
*References in bold text indicate studies that served 
as the basis of the SK assignment.
Table 2. Summary of the carcinogenic designations* for epichlorohydrin by 
numerous governmental and nongovernmental organizations
Organization Carcinogenic designation 
NIOSH [2005] Potential occupational carcinogen 
NTP [2009] Reasonably anticipated to be a human carcinogen
USEPA [2009] Group 2B: Probable human carcinogen (based on sufficient evidence of car-
cinogenicity in animals)
IARC [2009] Group 2A: Probably carcinogenic to humans
EC [2010] R45: May cause cancer
ACGIH [2001] A3: Confirmed animal carcinogen with unknown relevance to humans
Abbreviations: ACGIH = American Conference of Governmental Industrial Hygienists; EC = European 
Commission, Joint Research, Institute for Health and Consumer Protection; IARC = International 
Agency for Research on Cancer; NIOSH = National Institute for Occupational Safety and Health; 
NTP = National Toxicology Program; USEPA = United States Environmental Protection Agency.
*Note: The listed cancer designations were based on data from nondermal (such as oral or inhalation) ex-
posure rather than dermal exposure. 
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(SK: DIR) 
No data on the corrosivity of epichlorohy-
drin were identified, and there have been 
no in vitro tests for corrosivity in human 
skin models or for skin integrity in cadav-
er skin specimens. Findings on direct skin 
effects in humans are limited to those of a 
single study, by Dow Chemical Company 
[1970a], in which irritation effects were 
observed in 22 of 200 volunteers dermally 
administered epichlorohydrin. In animals, 
the degree of irritation following epichlo-
rohydrin application was dependent on 
the concentration and duration of expo-
sure. Application of 0.5 milliliter (mL) 
of undiluted liquid to rabbit skin for 24 
hours [Pallade et al. 1967] or of a 5% solu-
tion of epichlorohydrin in cottonseed oil 
for 2 to 24 hours [Lawrence et al. 1972] 
caused burns or necrosis. Doses of 0.1 to 
0.2 mL undiluted liquid applied to rab-
bit skin for 2 hours resulted in irritation 
over a small area that was less severe than 
with application of 0.5 mL [Pallade et al. 
1967]. A 0.3% solution in cottonseed oil 
applied under an occlusive patch for 24 
hours was not irritating [Lawrence et al. 
1972], and 0.1 mL applied over 24 hours 
produced barely perceptible irritation [Pal-
lade et al. 1967]. Mobay Chemical Cor-
poration [1967] reported that application 
of one drop of undiluted epichlorohydrin 
into rabbit ear caused no skin reaction, 
whereas one drop applied to the same skin 
spot four times in 1 hour caused distinc-
tive injury to the skin. Dow Chemical 
Company [1953] reported that exposing 
intact skin for a single short period (15 to 
20 minutes) to an unspecified volume of 
undiluted epichlorohydrin causes no skin 
reaction, but prolonged exposure results 
in severe burns. Patch tests with undiluted 
epichlorohydrin in rabbits produced ery-
thema and edema, with a primary irrita-
tion index of 4.84, indicating exposure to 
a moderate irritant [Proctor and Gamble 
1976]. Dow Chemical Company [1970a] 
reported a fatiguing response, in which re-
peated exposure to epichlorohydrin weak-
ened the ability of the skin to resist the 
effects of the chemical. The structure-ac-
tivity relationship model, Deductive Esti-
mation of Risk from Existing Knowledge 
(DEREKTM) for Windows, predicted epi-
chlorohydrin to be a skin irritant. 
Van Duuren [1974] conducted an initiation-
promotion study to determine the carcino-
genic potential of epichlorohydrin follow-
ing skin painting. Mice received a single 
application of 2.0 mg epichlorohydrin in 0.1 
mL acetone, followed by repeated applica-
tions of a tumor promoter, phorbol myristate 
acetate. The authors reported that epichlo-
rohydrin acted as a tumor initiator, result-
ing in the formation of skin papillomas and 
skin carcinoma. 
Taken together, findings from the human 
experience and animal studies demonstrate 
that undiluted liquid or solutions of >1% 
epichlorohydrin are corrosive [Lawrence et 
al. 1972], whereas diluted solutions (<1%) 
are irritating [Lawrence et al. 1972; Proc-
tor and Gamble 1976]. In addition, a single 
skin-painting study indicates that epichlo-
rohydrin is a tumor initiator. Therefore, on 
the basis of the data for this assessment, 
epichlorohydrin is assigned the SK: DIR 
(COR) notation. 
4 Immune-mediated 
Responses (SK: SEN) 
There is sufficient information avail-
able, from occupational exposure experi-
ence and animal studies, to conclude that 
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epichlorohydrin is a skin sensitizer. Several 
work-related cases of contact dermatitis or 
delayed skin sensitization attributable to 
dermal exposure to epichlorohydrin have 
been reported. For example, positive skin 
sensitization responses have been reported 
following patch tests with epichlorohydrin 
on patients with suspected contact der-
matitis [Prens et al. 1986; van Joost 1988, 
1990]. Other studies, such as those by 
Fregert and Gruvberger [1970] and Beck 
and King [1983], have demonstrated that 
epichlorohydrin caused hypersensitivity 
or contact dermatitis in humans. Incon-
sistent results have been observed in sen-
sitization studies with animals, primarily 
guinea pigs. For example, no sensitization 
was observed following repeated appli-
cation of epichlorohydrin to the skin of 
guinea pigs as a 0.01% solution in cotton-
seed oil (guinea pig maximization test, or 
GPMT) [Lawrence et al. 1972] or in an-
other study using 0.1 mL of diluted ma-
terial (concentration not specified) with 
a technique that involved intracutaneous 
injections [Weil et al. 1963]. However, 
in a Buehler test, 1 of 10 guinea pigs was 
sensitized after induction with 10% epi-
chlorohydrin in propylene glycol, followed 
by challenge concentrations of 0.1% or 1% 
in propylene glycol [Proctor and Gamble 
1976]. Dow Chemical Company [1970b] 
reported sensitization in 10 of 10 guinea 
pigs with use of a 0.4% v/v or 0.5% w/v 
solution of epichlorohydrin. Thorgeirs-
son and Fregert [1977] and Rao et al. 
[1981] observed sensitization with use of 
doses greater than 1%. A recent study that 
ranked contact allergen potency of over 
200 chemicals listed epichlorohydrin as a 
Category A skin sensitizer, demonstrating 
it is a significant contact allergen in hu-
mans and animals [Schlede et al. 2003]. 
DEREKTM predicted epichlorohydrin to 
be a skin sensitizer. 
On the basis of the human experience 
[Prens et al. 1986; van Joost 1988, 1990] 
and positive allergenicity results in ani-
mals [Dow Chemical Company 1970b; 
Thorgeirsson and Fregert 1977; Rao et 
al. 1981], there is adequate evidence that 
repeated or prolonged contact with epi-
chlorohydrin causes skin sensitization in 
humans. Therefore, on the basis of the 
data for this assessment, epichlorohydrin 
is assigned the SK: SEN notation. 
5 Summary 
Taken together, the systemic effects ob-
served in animals [Lawrence et al. 1972], 
the acute toxicity in rabbits [Lawrence et 
al. 1972; Hine et al. 1981], and the repeated- 
dose data [Shell Chemical Company 1977] 
are sufficient to demonstrate epichlorohydrin 
is acutely toxic and induces systemic effects 
following dermal exposure. It appears on the 
basis of limited human experience and ad-
equate animal data [Lawrence et al. 1972; 
Proctor and Gamble 1976] that undi-
luted epichlorohydrin is corrosive, but di-
luted (<1%) solutions are irritating. In ad-
dition, a single initiation-promotion study 
[Van Duuren 1974] demonstrated the 
ability of epichlorohydrin to act as a skin 
tumor initiator. The human experience 
[Prens et al. 1986; van Joost 1988, 1990] 
and positive allergenicity results in animal 
studies [Dow Chemical Company 1970b; 
Thorgeirsson and Fregert 1977; Rao et al. 
1981] adequately show that repeated or pro-
longed contact with epichlorohydrin causes 
skin sensitization in humans. Therefore, on 
the basis of these assessments, epichlorohy-
drin is assigned a composite skin notation 
of SK: SYS-DIR (COR)-SEN. 
Table 3 summarizes the skin hazard desig-
nations for epichlorohydrin previously is-
sued by NIOSH and other organizations. 
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The equivalent dermal designations for 
epichlorohydrin, according to the Globally 
Harmonized System (GHS) of Classifica-
tion and Labeling of Chemicals, are Acute 
Toxicity Category 3 (Hazard statement: 
Toxic in contact with the skin), Skin Cor-
rosion Category 1B (Hazard statement: 
Causes severe skin burns and eye damage), 
and Skin Sensitization Category 1 (Haz-
ard statement: May cause an allergic skin 
reaction) [European Parliament 2008]. 
Epichlorohydrin has been identified as a 
Category 1B Carcinogen (Hazard state-
ment: May cause cancer). 
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EpichlorohydrinAppendix: Calculation of the SI Ratio for Epichlorohydrin 
This appendix presents an overview of the 
SI ratio and a summary of the calculation 
of the SI ratio for epichlorohydrin. Al-
though the SI ratio is considered in the 
determination of a substance’s hazard po-
tential following skin contact, it is intend-
ed only to serve as supportive data during 
the assignment of the NIOSH SK. An 
in-depth discussion on the rationale and 
calculation of the SI ratio can be found 
in Appendix B of the Current Intelligence 
Bulletin (CIB) 61: A Strategy for Assign-
ing New NIOSH Skin Notations [NIOSH 
2009]. 
Overview 
The SI ratio is a predictive algorithm for 
estimating and evaluating the health haz-
ards of skin exposure to substances. The 
algorithm is designed to evaluate the po-
tential for a substance to penetrate the 
skin and induce systemic toxicity [NIOSH 
2009]. The goals for incorporating this al-
gorithm into the proposed strategy for as-
signing the SYS notation are as follows: 
1. Provide an alternative method to eval-
uate substances for which no clinical 
reports or animal toxicity studies exist 
or for which empirical data are insuf-
ficient to determine systemic effects.
2. Use the algorithm evaluation results to 
determine whether a substance poses a 
skin absorption hazard and should be 
labeled with the SYS notation.
The algorithm evaluation includes three 
steps: (1) determining a skin permeation 
coefficient (Kp) for the substance of in-
terest, (2) estimating substance uptake by 
the skin and respiratory absorption routes, 
and (3) evaluating whether the substance 
poses a skin exposure hazard. 
The algorithm is flexible in the data re-
quirement and can operate entirely on the 
basis of the physicochemical properties 
of a substance and the relevant exposure 
parameters. Thus, the algorithm is inde-
pendent of the need for biologic data. Al-
ternatively, it can function with both the 
physicochemical properties and the ex-
perimentally determined permeation co-
efficient when such data are available and 
appropriate for use. 
The first step in the evaluation is to deter-
mine the Kp for the substance to describe 
the transdermal penetration rate of the 
substance [NIOSH 2009]. The Kp, which 
represents the overall diffusion of the sub-
stance through the stratum corneum and 
into the blood capillaries of the dermis, is 
estimated from the compound’s molecular 
weight (MW) and base-10 logarithm of 
its octanol–water partition coefficient (log 
KOW). In this example, Kp is determined for 
a substance with use of Equation 1. A self-
consistent set of units must be used, such as 
centimeters per hour (cm/hr), outlined in 
Table A1. Other model-based estimates of 
Kp may also be used [NIOSH 2009]. 
Equation 1: Calculation of Skin Permeation 
Coefficient (Kp)
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where kpsc is the permeation coefficient 
in the lipid fraction of the stratum cor-
neum, Kpol is the coefficient in the protein 
fraction of the stratum corneum, and kaq 
is the coefficient in the watery epidermal 
layer. These components are individually 
estimated by
log Kpsc = −1.326 + 0.6097 × log KOW − 
   0.1786 × MW0.5
Kpol = 0.0001519 × MW −0.5
Kaq = 2.5 × MW −0.5 
The second step is to calculate the biologic 
mass uptake of the substance from skin 
absorption (skin dose) and inhalation (in-
halation dose) during the same period of 
exposure. The skin dose is calculated as a 
mathematical product of the Kp, the water 
solubility (SW) of the substance, the ex-
posed skin surface area, and the duration of 
exposure. Its units are milligrams (mg). As-
sume that the skin exposure continues for 
8 hours to unprotected skin on the palms 
of both hands (a surface area of 360 cm2).
Equation 2: Determination of Skin Dose 
Skin dose = Kp × SW × Exposed skin surface 
area × Exposure time
= Kp(cm/hr) × SW (mg/cm3) × 
360 cm2 × 8 hours
The inhalation dose (in mg) is derived on 
the basis of the occupational exposure limit 
(OEL) of the substance—if the OEL is de-
veloped to prevent the occurrence of sys-
temic effects rather than sensory/irritant 
effects or direct effects on the respiratory 
tract. Assume a continuous exposure of 
8 hours, an inhalation volume of 10 cubic 
meters (m3) inhaled air in 8 hours, and a 
factor of 75% for retention of the airborne 
substance in the lungs during respiration 
(retention factor, or RF). 
Equation 3: Determination of Inhalation Dose 
Inhalation dose = OEL × Inhalation 
volume × RF
= OEL (mg/m3) × 10 m3 
× 0.75 
The final step is to compare the calculated 
skin and inhalation doses and to present 
the result as a ratio of skin dose to inhala-
tion dose (the SI ratio). This ratio quan-
titatively indicates (1) the significance of 
dermal absorption as a route of occupa-
tional exposure to the substance and (2) 
the contribution of dermal uptake to sys-
temic toxicity. If a substance has an SI ra-
tio greater than or equal to 0.1, it is con-
sidered a skin absorption hazard.
Calculation
Table A1 summarizes the data applied in 
the previously described equations to deter-
mine the SI ratio for epichlorohydrin. The 
calculated SI ratio was 22.7. On the basis of 
these results, epichlorohydrin is predicted 
to represent a skin absorption hazard.
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Table A.1 Summary of data used to calculate the SI ratio for epichlorohydrin 
Variables used in calculation Units Value 
Skin permeation coefficient
Permeation coefficient of stratum corneum lipid 
path (Kpsc) cm/hr 0.0017
Permeation coefficient of the protein fraction of the 
stratum corneum (Kpol) cm/hr 1.57912 × 10-5
Permeation coefficient of the watery epidermal layer 
(Kaq) cm/hr 0.25990
Molecular weight (MW)* amu 93
Base-10 logarithm of its octanol–water partition co-
efficient (Log KOW)* None 0.45
Calculated skin permeation coefficient (Kp) cm/hr 0.00170
Skin dose
Water solubility (SW)* mg/cm3 65.9
Calculated skin permeation coefficient (Kp) cm/hr 0.00170
Estimated skin surface area (palms of hand) cm2 360
Exposure time hour 8
Calculated skin dose mg 323.45
Inhalation dose
Occupational exposure limit (OEL)† mg/m3 1.9
Inhalation volume m3 10
Retention factor (RF) None 0.75
Inhalation dose mg 14.25
Skin dose–to–inhalation dose (SI) ratio None 22.7
*Variables identified from SRC [2009].
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